HLTY.png
Source: PreCheck Health Services, Inc.

PreCheck Health Services, Inc. signs exclusive distribution agreement on the company’s new medical device

MIAMI, Jan. 22, 2019 (GLOBE NEWSWIRE) -- PreCheck Health Services, Inc. (OTC:HLTY) is a Florida corporation that has entered into an exclusive distribution agreement for the new PreCheck Health Services “PC8B” medical device for sale coast to coast in the United States.

The PC8B medical device is a powerful screening tool to provide physicians with data to help manage patient’s health. Scientifically validated and FDA cleared, this medical device performs a range of tests that are covered and reimbursed by Medicare and Medicaid as well as most insurance companies. The manufacturer holds multiple patents on the device and continues to evolve the technology. 

This system is non-invasive and combined with a fast ABI (Ankle Brachial Index) test, takes less than 8 minutes to complete an assessment. The device provides physicians with a one-page comprehensive overview of a patient’s health at-a-glance. The screening system provides patient insights covering key risk factors. Depending on the risk score for each factor, the physician will be able to determine the best course of action to resolve the patient’s condition, as well as motivate the patient to immediate action. The capabilities of the PC8B gives physicians the opportunity for early diagnosis and the ability to prevent many chronic conditions and diseases.

“By entering into this exclusive agreement we now can provide doctors with one of the best screening devices in the United States. Under the Affordable Care Act, physicians are being asked to provide more preventive care than previously required.  Insurance companies as well as Medicare and Medicaid have learned that preventive care will reduce their cost of insuring patients.  If chronic diseases are detected early, not only are we saving patients from the onset of chronic disease, the insurer and patient will save tens of thousands of dollars for care over the life of the patient,” stated Lawrence Biggs, the CEO of PreCheck Health Services, Inc.  

To learn more about how the PreCheck Health Services  “PC8B” medical device works, please view this excerpt from a training video for the device https://www.youtube.com/watch?v=4TEOwjMBTEE.

About PreCheck Health Services, Inc.

PreCheck Health Services Inc. is a Florida corporation focused on the exclusive U.S. distribution of a medical diagnostic device, the PC8B.  The PC8B medical device is a powerful screening tool in managing patient’s health. Scientifically validated and FDA cleared, this medical device performs a range of tests that are covered and reimbursed by most insurance companies. The manufacturer holds multiple patents on the device and continues to evolve the technology.  This system is non-invasive and combined with a fast ABI (Ankle Brachial Index) test, takes less than 8 minutes to complete an assessment. The device provides physicians with a comprehensive overview of a patient’s health at-a-glance. The screening system provides patient insights covering 8 key risk factors. Depending on the risk score for each factor, the physician will be able to determine the best course of action to resolve the patient’s condition, as well as motivate the patient to immediate action.

Connect with us: The Company’s website is: www.precheckhealthservices.com

Disclaimer for Forward-Looking Information:

This news release may contain forward-looking statements which include, but are not limited to, comments that involve future events and conditions, which are subject to various risks and uncertainties. Except for statements of historical facts, comments that address resource potential, upcoming work programs, geological interpretations, receipt and security of mineral property titles, availability of funds, and others are forward-looking. Forward-looking statements are not guarantees of future performance and actual results may vary materially from those statements. General business conditions are factors that could cause actual results to vary materially from forward-looking statements.

Investor inquiries contact:
Stuart Smith
SmallCapVoice.Com, Inc.

email: ssmith@smallcapvoice.com

P. 512-267-2430